Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)

Journal of Medicinal Chemistry
2014.0

Abstract

As the biology surrounding the nuclear receptor retinoic acid receptor-related orphan receptor-gamma (RORγ or RORc) continues to evolve, significant effort has been invested in discovering modulators of this potentially important target for the treatment of metabolic and immunological diseases. Several major pharmaceutical and biotechnology companies have disclosed RORc inhibitors or partnered with other players in the field. In this perspective, we discuss both the biology and the underlying structural biology of RORc, and summarize the RORc modulators disclosed in the scientific and patent literature.

Knowledge Graph

Similar Paper

Modulators of the Nuclear Receptor Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc)
Journal of Medicinal Chemistry 2014.0
Combating Autoimmune Diseases With Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ or RORc) Inhibitors: Hits and Misses
Journal of Medicinal Chemistry 2018.0
Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthetic modulators of the retinoic acid receptor-related orphan receptors
MedChemComm 2013.0
Discovery of biaryls as RORγ inverse agonists by using structure-based design
Bioorganic & Medicinal Chemistry Letters 2016.0
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt
Bioorganic & Medicinal Chemistry Letters 2014.0
Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation
European Journal of Medicinal Chemistry 2014.0
Structure–activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand
Bioorganic & Medicinal Chemistry 2014.0
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORc
Bioorganic & Medicinal Chemistry Letters 2013.0
Covalent Occlusion of the RORγt Ligand Binding Pocket Allows Unambiguous Targeting of an Allosteric Site
ACS Medicinal Chemistry Letters 2021.0